Open Access

Aspidosperma species as sources of anti-malarials: uleine is the major anti-malarial indole alkaloid from Aspidosperma parvifolium (Apocynaceae)

  • Maria Fâni Dolabela1,
  • Marinete Marins Póvoa2,
  • Geraldo Célio Brandão3,
  • Fabíola Dutra Rocha4,
  • Luciana Ferreira Soares5,
  • Renata Cristina de Paula5 and
  • Alaíde Braga de Oliveira1, 5Email author
Malaria Journal201514:498

DOI: 10.1186/s12936-015-0997-4

Received: 8 July 2015

Accepted: 18 November 2015

Published: 10 December 2015

Abstract

Background

Several species of the genus Aspidosperma (Apocynaceae) are used for the treatment of human malaria in Brazil and other meso- and South American countries.

Methods

Ethanol extract from Aspidosperma parvifolium trunk bark was submitted to acid–base extractions leading to alkaloid and neutral fractions. The alkaloid fraction was chromatographed over a silica gel column. Ethanol extract, fractions and uleine were analysed by HPLC–DAD, UPLC-ESI–MS/MS and HPLC-ESI-MicroTOF-MS. The anti-malarial activity was assayed against resistant and sensitive chloroquine Plasmodium falciparum strains by microscopic, [3H]-hypoxanthine incorporation and HRPII techniques. Cytotoxicity (CC50) was evaluated against Vero and HepG2 cell lines by the MTT technique; selectivity indexes (SI = CC50/IC50) were calculated.

Results

The major peak in the HPLC–DAD chromatograms of the ethanol extract, alkaloid and neutral fractions suggested the presence of uleine that was isolated from the alkaloid fraction by column chromatography and was characterized by spectroscopic methods. A total of 15 alkaloids, besides uleine, were identified in the alkaloid fraction by UPLC-DAD-ESI–MS/MS and HPLC-ESI-MicroTOF-MS. The ethanol extract from Aspidosperma parvifolium and the neutral fraction were moderately active against P. falciparum strains. The alkaloid fraction and uleine disclosed high anti-malarial activity against chloroquine-resistant P. falciparum strain (IC50 < 1 µg/mL). The ethanol extract, neutral fraction and uleine showed low cytotoxicity against Vero and HepG2 cell lines (CC50 > 300 µg/mL). The alkaloid fraction showed moderate cytotoxicity to HepG2 cell line (CC50 = 74.4 µg/mL). High SI values (>10) were determined for all samples.

Conclusion

Ethanol extract from Aspidosperma parvifolium trunk bark afforded uleine that is the major constituent of the alkaloid fraction and disclosed a good in vitro anti-malarial activity. Moreover, 15 other indole alkaloids have been identified along with uleine.

Keywords

Anti-malarial activity Plasmodium falciparum Alkaloids Uleine Apocynaceae Aspidosperma parvifolium

Background

Globally, 3.3 billion people are at risk of malaria, a disease endemic to more than 100 countries. According to latest estimates, 198 million cases of malaria and 584,000 deaths occurred in 2013; 90 % of all malaria deaths occurred in Africa and 78 % of all deaths in children under 5 years old [1]. The extensive use of anti-malarial drugs has imposed a high selective pressure on parasites, leading to the emergence of drug resistance, particularly in Plasmodium falciparum [2]. Plasmodium falciparum resistance to artemisinins has been detected in four countries of the Southeast Asia region. Artemisinin derivatives comprise the therapeutic scheme recommended for malaria treatment [3]. This points to the urgency for the development of new anti-malarial drugs. Plants continue to be a valuable source of bioactive compounds and investigation of traditional medicines used to treat malaria in endemic countries has afforded useful anti-malarial drugs, such as quinine, artemisinins and atovaquone [46].

Representatives of the genus Aspidosperma (family Apocynaceae, tribo Plumeriae) are found exclusively in the New World, from Mexico to Argentina [7], and several species have been traditionally used for the treatment of human malaria [811]. A recent review of the traditional use and anti-malarial activity of Aspidosperma species revealed several scientific bibliographical references on the use of 24 species to treat malaria/fevers, including Aspidosperma parvifolium, and to 19 Aspidosperma species that have had their extracts and/or alkaloids evaluated for in vitro and/or in vivo anti-malarial activity showing positive results. Only 20, out of more than 200 known indole alkaloids from Aspidosperma species have been assayed for anti-malarial activity, and variable levels of parasite inhibition have been reported [12].

Aspidosperma parvifolium is a tree of 10–15 m height, with a trunk diameter of 40–60 cm. It reaches approximately 4 m height in about 2 years when growing in the field and it is valuable as timber [13]. Its popular names in Brazil are peroba, pau-pereira, guatambu, guatambu-rosa, guatambu branco, guatambu-oliva, guatambu-marfim, amarelão [13, 14].

Uleine, 3-epi-uleine, apparicine, N-demethyluleine, lupeol, and stigmasterol were previously isolated from the trunk bark of Aspidosperma parvifolium [15]. Uleine stimulated a maximum nitric oxide production in the concentrations of 0.1 µg/mL (20.9 ± 1.4 µM) and 1 µg/mL (41.1 ± 0.2 µM) [16] and exhibited high level of acetylcholinesterase inhibition [17]. Uleine was evaluated for cytotoxicity against 65 cancer cell lines panel and it was inactive in all of them [18].

The present paper reports on the anti-malarial activity of Aspidosperma parvifolium against chloroquine-resistant (W2) and sensitive (3D7) P. falciparum strains. Moreover, phytochemical studies and cytotoxicity evaluations are also described.

Methods

Plant material, extraction and phytochemical studies

Trunk bark of Aspidosperma parvifolium was collected in the municipality of Paracatu, Minas Gerais, Brazil. A dried specimen was deposited in the Herbarium of the Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil (voucher number BHCB60345). Plant bark was dried in an oven with circulating air at 40 °C and milled. Powdered plant bark (2.5 kg) was extracted by percolation with ethanol 96 °GL. The extractive solution was concentrated in a rotary evaporator to give the crude ethanol extract (240 g, 9.6 %). An aliquot of ethanol extract (55.2 g) was suspended in aq. HCl 1 N (500 mL) and was extracted with dichloromethane (5 × 200 mL). The organic solvent was removed in a rotary evaporator affording the neutral fraction (8.7 g). The aqueous solution was made alkaline (pH 10) with conc. ammonium hydroxide, followed by extraction with dichloromethane (5 × 200 mL). Solvent concentration in a rotary evaporator afforded the alkaloid fraction (3.8 g). Part of the alkaloid fraction (1.0 g) was chromatographed in a silica gel column eluted with solvents and mixtures of solvents of increasing polarities. Fractions eluted with ethyl acetate–methanol were combined (507 mg) and chromatographed on a silica gel column affording uleine as white crystals (49 mg).

The ethanol extract, alkaloid fraction, neutral fraction, and uleine were analysed by high performance liquid chromatography with diode array detector (HPLC–DAD, Waters mod. 2695, USA), C-18 reverse phase column (5 μm, 125 × 45 mm, LiChrocart 125-4, Merck, Germany), at 40 °C, flow rate of 1 mL/min, wavelengths scanning from 220 to 400 nm. The mobile phases were a buffer solution pH 5.0 of acetic acid with 0.2 %, triethylamine (A) and acetonitrile (B) in the following programme of elution: t = 0 min, A = 90 %; t = 10 min, A = 80 %; t = 30 min, A = 50 %; t = 35 min, A = 90 %. After 35 min acetonitrile 95 % was used for 10 min to wash the column.

Analyses by ultra-performance liquid chromatography coupled to UV and mass spectrometry by electron spray ionization (UPLC-DAD-ESI-MSMS) were performed in an Acquity H-Class Core System® Waters equipment; the positive mode was used for ESI-MSMS, with capillary voltage of 3.5 eV, the cone 60 eV, CSH130 C-18 column (particles of 1.7 μm, 50 × 3 mm), flow of 0.3 mL/min, temperature of 40 °C and UV detection between 220 and 400 nm. As mobile phase, a linear gradient was used, in which the initial time contained aqueous solution of formic acid 0.1 % (A) and acetonitrile with formic acid 0.1 % (B), in 10 min 5 % of A and 95 % B. Operating parameters of the mass spectrometer were capillary temperature 250 °C; spray needle voltage set at 3.50 kV; ES capillary voltage +3 and −47 V for positive and negative polarity, respectively; tube lens offset 0 and −25 V for positive and negative polarity, respectively. Nitrogen was used as a sheath gas with a flow of 50 arbitrary units. Mass analyses were carried out in full-scan mode from 100 to 1500 Da, in both positive and negative mode. UV spectra (200–400 nm) from the main peaks were registered on line.

Uleine was identified on the basis of spectroscopic methods (Ultraviolet/UV, Infra-red/IR, 1H and 13CNMR (Hydrogen and Carbon-13 Nuclear Magnetic Resonance) and direct comparison with authentic sample previously isolated at UFMG [15].

Anti-malarial activity

Plasmodium falciparum W2 (resistant to chloroquine) and 3D7 (sensitive to chloroquine) strains were maintained in continuous culture in human erythrocytes (blood group O+) in RPMI medium supplemented with 10 % human plasma (complete medium) [19]. Synchronization of parasites was achieved by sorbitol treatment [20] and parasitaemia was microscopically determined in Giemsa-stained smears.

In vitro growth inhibition of Plasmodium falciparum (W2 and 3D7) by the microscopic method

Parasites in the trophozoite stage were used (parasitaemia of 1 % and haematocrit of 0.5 %) and different concentrations of test samples (≤100 μg/mL). Chloroquine was used as a standard anti-malarial drug. After 72 h of incubation under CO2, stained with Giemsa were prepared.

The antiparasitic effects of the extracts/fractions/compounds were measured by the per cent inhibition of parasite growth in relation to the control (parasites cultivated in drug-free medium) [21]. The 50 % inhibitory concentrations (IC50), compared to the drug-free control responses, were estimated by linear interpolation [22]. Each experiment was performed in triplicate and repeated three times. The blood smears were read in a double-blind manner. The IC50 was determined by means of linear regression curve. The following criteria being adopted: IC50 10 μg/mL, good activity; IC50 >100 μg/mL, inactive; IC50 of 10–50 μg/mL, moderate activity; and, IC50 of 50–100 μg/mL, low activity [23].

In vitro growth inhibition of Plasmodium falciparum (W2 and 3D7) by [3H]-hypoxanthine incorporation

Trophozoite stage parasites (1 % parasitaemia and 0.5 % haematocrit), different concentrations of test samples (≤100 μg/mL) and chloroquine as standard anti-malarial drug were used in the assays. After 24 h incubation period, 25 µL of medium containing [3H]-hypoxanthine (0.5 µCi/well) (PerkinElmer) was added per well, followed by another 18 h incubation at 37 °C [24]. The cells were harvested (Cell Harvester PerkinElmer) on glass fibre filters (Filtermat A, PerkinElmer) then placed onto sample bags (PerkinElmer) and immersed in scintillation fluid (UltimaGold, PerkinElmer). Radioactive emission was counted in a 1450 Microbeta TriLux Microplate Scintilation and Luminescence Counter (PerkinELmer). The inhibition of parasite growth was evaluated from the levels of [3H]-hypoxanthine incorporation, i.e., IC50 values were evaluated by comparing the incorporation in drug-free control cultures and estimated by linear interpolation [25] using curve fitting software (Microcal Origin software 8.5). All experiments were performed three times, and each sample was tested in triplicate.

In vitro growth inhibition of Plasmodium falciparum (W2) by HRPII method

HRPII assays were performed as previously described [26]. Briefly, cultures of P. falciparum (1.5 % haematocrit, 0.05 % parasitaemia) were placed in 96-well microplates with the extracts/fractions/compounds and controls at different concentrations, and were incubated for 48 h at 37 °C. After 24 h incubation, the content of six wells corresponding to medium and no test sample controls were harvested and frozen in microtubes, to allow subtracting the average value obtained from these wells from the other wells for excluding the background value (production of HRP2 during the first 24 h of incubation). After a total of 48 h incubation, the plates were frozen and thawed twice for total erythrocyte lyses and 100 µL/well of the material was placed in another plate for the ELISA test. This plate was pre-coated overnight at 4 °C with 1 mg/ml of the primary antibody anti-HRPII (MPFM-55A ICLLABs) and then the content was discarded, replaced by the blocking solution (PBS/BSA 2 % 200 µl/well), incubated for 2 h, and finally the content was discarded. The haemolyzed cultures were transferred to the ELISA pre-coated plate, incubated (1 h, room temperature), discarded, incubated for 1 h with 0.05 mg/mL of the secondary antibody (MPFG55P-ICLLAB; 100 µL/well), then incubated with 100 µL/well of TMB chromogen (15 min at room temperature) in the dark. The reaction was stopped with 50 mL/L of 1 M sulfuric acid and the absorbance was read at 450 nm in a spectrophotometer (Infinite®200 PRO, Tecan). The results were evaluated with the software MicrocalOrigin 8.5 for determination of the dose–response curves plotted with sigmoidal fit. The 50 % inhibitory concentration growth of the parasites (IC50) was determined by comparison with controls with standard drug and without drugs.

Cytotoxicity assays

Cell viability was determined by the MTT [3- (4,5- dimethyltrazol-2-yl)-2,5-diphenyl tetrazolium bromide] method according to Mosman [27]. HepG2 A16 cells and Vero (4 × 105 cells/0.1 mL) were grown in RPMI-1640 (Roswell Park Memorial Institute 1640) medium (Sigma Aldrich®, USA), supplemented with 5 % of fetal calf serum, kept in a 5 % CO2 atmosphere at 37 °C. The ethanol extract from Aspidosperma parvifolium, fractions and uleine were solubilized in RPMI-1640 and dimethyl sulfoxide (0.02 %, v/v). After 24 h, the solution was added at different concentrations (in μg/mL: 1, 10, 100, 1000), followed by 24 h of further incubation. The MTT (2.0 mg/mL) was added, followed by incubation at 37 °C in an atmosphere of 5 % CO2 for 4 h. Dimethyl sulfoxide was added to each well to solubilize the formazan crystals. The optical density was determined at 492 nm (Vero cells) and 570 nm (HepG2 cells; Stat Fax 2100 microplate reader, Awareness Technology, Inc, USA). The cell viability was expressed as a percentage of the control absorbance in the untreated cells after subtracting the appropriate background and the average cytotoxic concentration (CC50) was determined by linear regression. Samples with CC50 >200 μg/mL were considered of low cytotoxicity. Selectivity index (SI) for the anti-malarial activity was then calculated based on the rate between CC50 and IC50 for the in vitro activity against P. falciparum [28].

Results

Phytochemical studies

HPLC–DAD chromatograms showed a peak for the same major component in the ethanol extract (RT = 30.1 min; Fig. 1a), alkaloid fraction (RT = 29.6 min, Fig. 1b) and neutral fraction (RT = 29.8 min, Fig. 1c) that might correspond to uleine (Fig. 1d). The UV spectra are suggestive of indole alkaloid [29] (Fig. 1a–d).
Fig. 1

HPLC-DAD profiles of Aspidosperma parvifolium trunk bark ethanol extract and fractions. a Trunk bark ethanol extract (EEAP); b alkaloid fraction (EEAPA); c neutral fraction (EEAPN); d uleine

The on-line UPLC-DAD  chromatogram of the alkaloid fraction shows also a predominant peak (RT = 3.49 min) (Fig. 2) related to indole alkaloids (Fig. 2). This peak must correspond to the most intense one in Fig. 1a–c. The difference in retention times (RT) is a consequence of the different mobile phases used in the experiments as well as to the different equipments in each case, HPLC and UPLC.
Fig. 2

UPLC-DAD profile of Aspidosperma parvifolium trunk bark alkaloid fraction. (1) Spegazzinidine, (2) 1,13-Dihydro-13-hydroxyuleine, (3) aspidocarpine, (4) deacetylaspidospermine, (5) pyrifolidine, (6) 1-methyldeacetylaspidospermidine, (7) dasycarpidone, (8) aspidospermidin-19-ol, (9) N-acetylaspidospermidine, (10) N-demethyluleine, (11) apparicine, (12) uleine, (13) 3-epi-uleine, (14) aspidospermine, (15) dasycarpidol, (16) dasycarpidan

The UPLC-ESI–MS spectrum of the alkaloid fraction disclosed distinct peaks for uleine and 3-epi-uleine, demonstrating that superposition of these alkaloids peaks was occurring in Figs. 1a–c and 2. This behaviour is a consequence of the close polarity of these two molecules that are just epimers at C-3 position and explains the difficulty for isolation of pure uleine although being the major alkaloid fraction constituent. Further analyses of the alkaloid fraction was performed by tandem mass spectrometry (UPLC-ESI–MS/MS) (Fig. 3), a variant of HPLC that affords significant advantages in resolution, speed, and sensitivity for analytical determinations, particularly when coupled to mass spectrometers capable of high-speed acquisitions allowing studies on the fragmentations of each component under electron spray conditions [30]. The observed mass fragments (Table 1) are consistent with the structural classes of these alkaloids that belong to the aspidospermane and plumerane types, [3134] and full fragmentation mechanisms will be published elsewhere. Only six out of the 16 alkaloids identified have been previously isolated from Aspidosperma parvifolium, e.g., N-methyltetrahydroellipticine, uleine, 3-epi-uleine, N-demethyluleine, N-demethyl-dihydrouleine, and apparicine [15, 35] (Fig. 4).
Fig. 3

UPLC-ESI–MS spectrum of Aspidosperma parvifolium trunk bark alkaloid extract. (1) Spegazzinidine, (2) 1,13-dihydro-13-hydroxyuleine, (3) aspidocarpine, (4) deacetylaspidospermine, (5) pyrifolidine, (6) 1-methyldeacetylaspidospermidine, (7) dasycarpidone, (8) aspidospermidin-19-ol, (9) N-acetylaspidospermidine, (10) N-demethyluleine, (11) apparicine, (12) uleine, (13) 3-epi-uleine, (14) aspidospermine, (15) dasycarpidol, (16) dasycarpidan

Table 1

Alkaloids identified in Aspidosperma parvifolium trunk bark alkaloid extract by UPLC-DAD-ESI–MS/MS and HPLC-ESI-MICROTOF-MS

Compounds

Peak number

Rt (min) UPLC-ESI-MS

UV λmax (nm) UPLC-DAD

[M+H]+

UPLC-ESI-MS (m/z)

HRMS HPLC-ESI-

MICROTOF-MS (m/z)

UPLC-ESI-MS/MS fragments (m/z)

Spegazzinidine

1

2.06

317.13

373.43

 

373.11, 354.90, 341.10, 323.90, 311.42, 295.0, 279.10, 247.79, 231.91, 205.95, 183.71, 124.07, 108.86

1,13-Dihydro-13- hydroxyuleine

2

2.26

316.13

285.36

285.1949

285.11, 254.11, 238.10, 236.29, 210.16, 208.0, 206.01, 197.97, 195.15, 182.15, 168.15, 167.02, 155.96, 144.02, 130.02, 124.07, 121.89

Aspidocarpine

3

2.50

304.13

371.40

371.1975

371.22, 353.95, 339.21, 321.0, 270.22, 249.68, 245.90, 227.69, 220.13, 199.71, 173.75, 154.10, 152.08, 142.88, 107.97

Deacetylaspidospermine

4

2.60

317.13

313.38

313.1953

313.08, 251.89, 222.09, 206.08, 180.12, 168.03, 151.96, 140.05, 131.92

Pyrifolidine

5

2.62

317.13

385.45

385.14, 367.12, 353.07, 327.11, 309.09, 256.10, 231.97, 167.89, 121.07

1-Methyldeacetyl-aspidospermidine

6

2.88

310.13

327.37

327.2061

327.01, 309.16, 296.15, 283.14, 278.30, 252.21, 236.19, 197.97, 170.0, 168.24, 130.72, 129.21

Dasycarpidone

7

2.74

319.13

269.35

269.1628

238.16, 210.12, 209.04, 192.16, 182.11, 167.06, 130.01

Aspidospermidin-19-ol

8

3.25

302.13

299.40

299.1806

299.15, 252.02, 234.75, 233.75, 221.33, 208.10, 206.34, 196.07, 169.16, 159.39, 150.07, 138.03, 122.97, 109.17

N-Acetylaspidospermidine

9

3.27

303.13

341.35

341.1856

341.15, 322.96, 309.17, 304.58, 295.20, 294.07, 281.29, 266.8, 251.90, 236.22, 223.01, 183.73, 168.12, 121.86, 107.82

Des-N-methyluleine

10

3.35

304.13

253.34

253.1686

236.10, 221.10, 208.09, 207.16, 206.03, 194.09, 193.03, 182.03, 181.03, 167.02

Apparicine

11

3.39

303.13

265.36

265.1678

265.11, 250.02, 236.12, 222.16, 208.14, 207.20, 206.09, 194.12, 180.0, 158.03, 134.01, 108.17

Uleine

12

3.49

303.13

267.39

267.1845

236.10, 221.04, 208.09, 207.09, 206.16, 193.03, 182.09, 167.02

Epi-uleine

13

3.53

304.13

267.69

267.1853

236.16, 221.04, 208.09, 207.03, 206.03, 194.03, 193.03, 182.03, 181.03, 167.02

Aspidospermine

14

3.63

297.13

355.46

355.1993

355.14, 323.30, 313.08, 268.19, 256.22, 218.07, 173.81, 164.17, 124.01, 122.05

Dasycarpidol

15

3.88

304.13

283.40

283.1793

236.23, 221.04, 208.09, 207.09, 206.16, 193.09, 192.15, 181.50, 167.0

Dasycarpidan

16

5.51

303.13

281.30

-

281.05, 236.07, 222.08, 194.04

(−) species not detected

Rt retention time, UV ultraviolet, UPLC-DAD-ESI–MS ultra performance liquid chromatography photo diode array electron spray mass spectrometry, HRMS high resolution mass spectrometry, HPLC-ESI-MICROTOF-MS high performance liquid chromatography electro spray ionization time-of-flight mass spectrometry

Fig. 4

Chemical structures of the indole alkaloids identified in Aspidosperma parvifolium trunk bark alkaloid extract

The chemical structure of uleine was characterized by spectroscopic data (UV, IR, MS and NMR) in comparison with literature data [15, 28, 36] and its identification was confirmed by direct comparison with authentic sample that was previously isolated at UFMG [15].

Anti-malarial activity

The ethanol extract of Aspidosperma parvifolium trunk bark disclosed a good in vitro activity against P. falciparum W2 strain by the HRPII assay (IC50 = 10.11 ± 2.22 µg/mL) and a moderate activity by the microscopic method against parasite W2 and 3D7 strain (IC50 = 32.75 ± 1.06 and 20.51 ± 0.70 µg/mL, respectively). Higher IC50 values were determined by the [3H]-hypoxanthine method against W2 and 3D7 strains (IC50 = 42.51 ± 6.33 and 38.20 ± 0.33 µg/mL, respectively) (Table 2). The neutral fraction was active against parasite W2 strain by the HRPII method (IC50 = 9.71 µg/mL) and its IC50 was close to that one of the ethanol extract (IC50 = 10.11 ± 2.22 µg/mL) against the same parasite strain. The alkaloid fraction and uleine were very active disclosing close IC50 values against the parasite W2 strain by the three methods, the lowest value being determined by the microscopic method: 0.98 ± 0.20 and 0.75 ± 0.10 µg/mL, respectively. Higher IC50 values were determined for all the samples against W2 parasite by the radioisotopic method than by the microscopic method and it was approximately ten-fold higher for the alkaloid fraction and uleine. For the purpose of comparison, the data on the anti-malarial activity of apparicine, aspidocarpine, and ellipticine, the only previously assayed alkaloids [37, 38] out of the 16 here identified in Aspidosperma parvifolium, are included in Table 2.
Table 2

Antiplasmodial activity of ethanol bark extract of Aspidosperma parvifolium, fractions and uleine along with literature data for apparicine, aspidocarpine, and ellipticine

Extract/fractions/compounds

IC50 (µg/mL) P. falciparum W2

IC50 (µg/mL) P. falciparum 3D7

MM

HM

HRPII

MM

HM

Choroquine

0.02 ± 0.002

0.018 ± 0.0005

0,0856 ± 0.0201

0.0013 ± 0.0001

0.002 ± 0.0004

Mefloquine

0.016 ± 0.002

0.044 ± 0.008

ND

0.048 ± 0.0007

0.052 ± 0.0006

EEAP

32.75 ± 1.06

42.51 ± 6.33

10,11 ± 2,22

20.51 ± 0.70

38.20 ± 0.33

EEAPA

0.98 ± 0.20

8.0 ± 1.19

0.43 ± 0.11

7.63 ± 0.31

43.05 ± 4.30

EEAPN

15.02 ± 2.83

38.02 ± 3.76

9,71 ± 2,63

17.75 ± 0.35

18.2 ± 1.75

Uleine

0.75 ± 0.10

8.78a

2.95 ± 1.47

11.90 ± 0.10

ND

Apparicineb

 

3.0 ± 1.4

3.2 ± 2.7

  

Aspidocarpineb

 

5.4 ± 2.5

4.4 ± 0.8

  

Ellipticinec

0.018

    

EEAP ethanol extract of Aspidosperma parvifolium trunk bark, EEAPA alkaloid fraction prepared from EEAP, EEAPN neutral fraction prepared from EEAP, MM microscopic method, HM [3H]-hypoxanthine method, ND not determined

aone triplicate experiment

bRef. [36] P. falciparum W2

cRef. [35] P. falciparum K1

Differences in the IC50 values for the microscopic method and the radioisotopic assay might be related to the time of incubation of the parasites with the samples: 72 and 42 h, respectively. However, for the radioisotopic assay and the HRPII method that has had similar incubation times, an important factor that might explain these differences, might be the intrinsic sensitivity of each technique. Interestingly, higher potency was generally observed against parasite W2 strain, which is chloroquine resistant, than against the 3D7 strain, a chloroquine-sensitive P. falciparum strain, except for the ethanol extract.

The relatively close IC50 values for the neutral fraction and the crude ethanol extract (Table 2) could be explained by the fact that alkaloids are still present in the neutral fraction indicating that the acid–base process used for extraction of alkaloids from the ethanol extract was not complete, as is shown by the HPLC–DAD chromatogram (Fig. 1c).

It is interesting to call attention for the fact that, only three (apparicine, aspidocarpine and ellipticine) out of the 16 identified alkaloids in the trunk bark of Aspidosperma parvifolium were previously evaluated against P. falciparum [37, 38]. Ellipticine is the most active alkaloid amongst those shown in Table 2 but it is highly cytotoxic while uleine was not active against a panel of tumoral cells [18].

Uleine is a monoterpenoid indole alkaloid and its chemical structure can be related to those of quinine and synthetic quinoline anti-malarials, such as chloroquine, with the nitrogen of the indole unit corresponding to that of the quinoline system. These nitrogens are of low basicity. A second nitrogen, of a tertiary amine, and therefore of higher basicity, is present in both the systems. The quinoline system is the pharmacophore that plays a crucial role in the complexation to ferriprotoporphyrin IX (FPIX) resulting in inhibition of haemozoin formation and parasite growth. On the other hand, the presence of a basic amino group in the side chain is generally considered essential for trapping high concentrations of the drug in the acidic digestive vacuole of the parasite. It is known that these structural characteristics are important for the inhibition of the haem polymerization, the mechanism of action of quinolines as anti-malarials [39] and, possibly, of the monoterpenoid indole alkaloids, as well.

Recently, uleine was isolated from Aspidosperma olivaceum and its anti-malarial activity was also evaluated against the chloroquine-resistant strain W2 by the HRPII (IC50 = 3.2 ± 1.8 mg/mL) and the [3H]-hypoxanthine (IC50 = 7.0 ± 0.0 mg/mL) assays [38]. These data confirm the results reported here and point to uleine as a novel anti- malarial hit.

Citotoxicity and selectivity index (SI)

The ethanol extract was not cytotoxic to Vero and HepG2 cell lines up to the concentrations of 500 and 1000 mg/mL, respectively. Fractionation of ethanol extract led to fractions of higher cytotoxicity (Table 3). The neutral fraction showed low cytotoxicity against both Hep G2A16 and Vero cell lines (CC50 = 251.0 and 449.3 μg/mL, respectively). The alkaloid fraction was more cytotoxic to HepG2 (CC50 74.4 ± 15.5 µg/mL) than to Vero cells (CC50 299.7 µg/mL) (Table 3). On the other hand, chromatographic fractionation of the alkaloid extract led to uleine that showed low cytotoxicity against both Hep G2A16 and Vero cell lines (CC50 = 374.6 and 301.2 μg/mL, respectively). The low cytotoxicity of uleine against 65 human cancer cell lines was previously reported [18]. Surprisingly, a higher cytotoxicity of uleine (CC50 = 52 ± 10.0 μg/mL) to HepG2 cell line was recently assigned [38]. The extract, neutral fraction and uleine disclosed high selectivity indexes (SI > 10) (Table 3) while lower selectivity was determined for the 3D7 chloroquine-sensitive strain of P. falciparum (SI < 10) (Table 3). In summary, uleine disclosed high SI and greater selectivity for the resistant strain W2, than the ethanol extract and the alkaloid fraction (Table 3).
Table 3

Cytotoxicity of ethanol extract trunk bark of Aspidosperma parvifolium, derived fractions and uleine to Vero and HepG2 cells

Extract/fractions/compounds

Vero cells

HepG2 cells

CC50 (µg/mL)

SI W2

SI 3D7

CC50 (µg/mL)

SI W2

SI 3D7

EEAP

>500

>15.3

>24.4

>1000

30.5

48.7

EEAPA

299.7

305.8

39.3

74.4

75.9

9.7

EEAPN

449.3

29.9

25.3

251.0

16.7

14.1

Uleine

374.6

499.5

31.5

301.2

407.6

25.3

Chloroquine

ND

ND

Nd

185.0

9250.0

142,307.7

EEAP ethanol extract of Aspidosperma parvifolium trunk bark, EEAPA alkaloid fraction prepared from EEAP, EEAPN neutral fraction prepared from EEAP, SI selectivity index

When relating anti-malarial activity and cytotoxicity, it is noted that the fractionation performed was successful. Although no significant difference is observed between the IC50 values determined for uleine and the alkaloid fraction (Table 2), they are however quite distinct with respect to the cytotoxicity (CC50), uleine being safer (less cytotoxic) (Table 3).

Conclusion

Ethanol extract of Aspidosperma parvifolium trunk bark afforded uleine that discloses high in vitro anti-malarial activity and selectivity against the chloroquine-resistant P. falciparum strain W2. Besides, the alkaloid fraction showed anti-malarial activity similar to uleine. However, uleine showed lower cytotoxicity and increased SI when compared to the alkaloid fraction. Uleine was demonstrated to be the major constituent in the alkaloid fraction of Aspidosperma parvifolium trunk bark and 15 other indole alkaloids have been identified along with uleine. The high chemical diversity of alkaloids from Aspidosperma species and the small number of these alkaloids that have been assayed for anti-malarial activity coupled to the traditional use of several species of this taxon to treat malaria in Brazil, as well as in other meso- and South American countries, make further investigations of plants in this genus of great interest in the quest for natural anti-malarial drugs [12].

Declarations

Authors’ contributions

MFD carried out the phytochemical work including isolation and characterization of uleine as part of her PhD thesis presented at PPGCF/UFMG/Belo Horizonte/Brazil. Antiplasmodial assays were performed by MFD under the supervision of MMP, with the collaboration of RCP and LFS. GCB and FDR are responsible for UPLC-PDA-MS/MS and HPLC–DAD studies. ABO conceived of the study, provided the plant material, supervised MFD, participated in its design and coordination and drafted the manuscript jointly with GCB, MFD and RCP. All authors read and approved the final manuscript.

Acknowledgements

The authors gratefully acknowledge the financial support from the Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq, (PRONEX Process 555655/2009–1) and Fundação de Amparo à Pesquisa do Estado de Minas Gerais—FAPEMIG (PRONEX Process CDS APQ 01129–10).

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Programa de Pós-Graduação em Ciências Farmacêuticas, Instituto de Ciências da Saúde, Universidade Federal do Pará
(2)
Laboratório de Malária, Seção de Parasitologia, Instituto Evandro Chagas
(3)
Escola de Farmácia, Universidade Federal de Ouro Preto
(4)
Faculdade de Farmácia e Bioquímica, Universidade Federal de Juiz de Fora
(5)
Faculdade de Farmácia, Universidade Federal de Minas Gerais

References

  1. WHO. World malaria report 2014. World Health Organization, Geneva. 2014. http://www.who.int/malaria/publications/world_malaria_report_2014/report/en/.
  2. Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010;8:272–80.View ArticlePubMedGoogle Scholar
  3. WHO. Status report on artemisinin resistance. In: Global malaria program. Geneve. 2014. http://www.who.int/malaria/publications/atoz/status_rep_artemisinin_resistance_jan2014.pdf.
  4. Ginsburg H, Deharo E. A call for using natural compounds in the development of new antimalarial treatments—an introduction. Malar J. 2011;10:1–7.View ArticleGoogle Scholar
  5. Kaur K, Jain M, Kaur T, Jain R. Antimalarials from nature. Bioorg Med Chem. 2009;17:3229–56.View ArticlePubMedGoogle Scholar
  6. Wright CW. Recent developments in research on terrestrial plants used for the treatment of malaria. Nat Prod Rep. 2010;27:961–8.View ArticlePubMedGoogle Scholar
  7. Milliken W, Albert B. The use of medicinal plants by the Yanomami Indians of Brazil. Econ Bot. 1996;50:10–25.View ArticleGoogle Scholar
  8. Dolabela MF, Oliveira SG, Peres JM, Nascimento JM, Povoa MM, Oliveira AB. In vitro antimalarial activity of six Aspidosperma species from the state of Minas Gerais (Brazil). An Acad Bras Cienc. 2012;84:899–910.View ArticlePubMedGoogle Scholar
  9. Mariath IR, Falcão HS, Barbosa-Filho JM, Sousa LCF, Tomaz ACA, Batista LM, et al. Plants of the American continent with antimalarial activity. Braz J Pharmacog. 2009;19:158–91.Google Scholar
  10. Milliken W, Albert B. The use of medicinal plants by the Yanomami Indians of Brazil. Part II. Econ Bot. 1997;51:264–78.View ArticleGoogle Scholar
  11. Oliveira AB, Dolabela MF, Braga FC, Jacome RL, Varotti FP, Povoa MM. Plant-derived antimalarial agents: new leads and efficient phythomedicines. Part I. Alkaloids. An Acad Bras Cienc. 2009;81:715–40.View ArticlePubMedGoogle Scholar
  12. De Paula RC, Dolabela MF, Oliveira AB. Aspidosperma species as sources of antimalarials. Part III. A review of traditional use and antimalarial activity. Planta Med. 2014;80:378–86.View ArticlePubMedGoogle Scholar
  13. Lorenzi H. Árvores brasileiras: manual de identificação e cultivo de plantas arbóreas nativas do Brasil. 2nd ed. Nova Odessa: Instituto Plantarum; 1998.Google Scholar
  14. Almeida MR, Lima JA, dos Santos NP, Pinto AC. Pereirina: o primeiro alcalóide isolado no Brasil? Braz J Pharmacog. 2009;19:942–52.Google Scholar
  15. Jácome RLRP, Oliveira AB, Raslan DS, Wagner H. Chemical constituents and chromatographic profile of the stem bark of Aspidosperma parvifolium A. DC. (“ pau-pereira”). Quim Nova. 2004;27:897–900.View ArticleGoogle Scholar
  16. Souza WM, Brehmer F, Nakao LS, Stinghen AE, Santos CA. Ação da uleína sobre a produção de óxido nítrico em células RAEC e B16F10. Rev Bras Farmacogn. 2007;17:191–6.View ArticleGoogle Scholar
  17. Seidl C, Correia BL, Stinghen AE, Santos CA. Acetylcholinesterase inhibitory activity of uleine from Himatanthus lancifolius. Z Naturforsch C. 2010;65:440–4.View ArticlePubMedGoogle Scholar
  18. PubChem Substance. 2013. http://pubchem.ncbi.nlm.nih.gov/substance/115962#x299. Accessed 23 May 2013.
  19. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673–5.View ArticlePubMedGoogle Scholar
  20. Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979; 418-20.
  21. Rieckmann KH, Campbell GH, Sax LJ, Mrema JE. Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique. Lancet. 1978;1:22–3.View ArticlePubMedGoogle Scholar
  22. Huber W, Koella JC. A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Trop. 1993;55:257–61.View ArticlePubMedGoogle Scholar
  23. Dolabela MF. Atividade antiplasmódica e citotoxicidade de Esenbeckia febrifuga (A.St-Hil.) Juss. ex Mart. (Rutaceae) e de espécies do gênero Aspidosperma (Apocynaceae) [PhD thesis] 2007.
  24. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710–8.PubMed CentralView ArticlePubMedGoogle Scholar
  25. de Madureira MDC, Martins AP, Gomes M, Paiva J, da Cunha AP, do Rosário V. Antimalarial activity of medicinal plants used in traditional medicine in S, Tomé and Prıncipe islands. J Ethnopharmacol. 2002;81:23–9.View ArticleGoogle Scholar
  26. Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother. 2005;49:3575–7.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.View ArticlePubMedGoogle Scholar
  28. Mitaine-Offer AC, Sauvain M, Valentin A, Callapa J, Mallie M, Zeches-Hanrot M. Antiplasmodial activity of Aspidosperma indole alkaloids. Phytomed. 2002;9:142–5.View ArticleGoogle Scholar
  29. Sangster AW, Stuart KL. Ultraviolet spectra of alkaloids. Chem Rev. 1965;65:69–130.View ArticleGoogle Scholar
  30. Churchwell MI, Twaddle NC, Meeker LR, Doerge DR. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;825:134–43.View ArticlePubMedGoogle Scholar
  31. Aguiar GP, Wakabayashi KA, Luz GF, Oliveira VB, Mathias L, Vieira IJ, et al. Fragmentation of plumeran indole alkaloids from Aspidosperma spruceanum by electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2010;24:295–308.View ArticlePubMedGoogle Scholar
  32. Biemann K. Four decades of structure determination by mass spectrometry: from alkaloids to heparin. J Am Soc Mass Spectrom. 2002;13:1254–72.View ArticlePubMedGoogle Scholar
  33. Joule JA, Ohashi M, Gilbert B, Djerassi C. Alkaloid studies. 53. The structures of nine new alkaloids from Aspidosperma dasycarpon A. DC. Tetrahedron. 1965;21:1717–34.View ArticlePubMedGoogle Scholar
  34. Li-Mei L, Guo-You L, Dong-Mei F, Zhi-Jun W, Guo-Lin Z. Analysis of monoterpenoid indole alkaloids using electrospray ionization tandem mass spectrometry. Chem Nat Comp. 2015;51:116–20.View ArticleGoogle Scholar
  35. Pereira MM, Jacome R, Alcântara A, Alves RB, Raslan DS. Alcalóides indólicos isolados de espécies do gênero Aspidosperma (Apocynaceae). Quim Nova. 2007;30:970–83.View ArticleGoogle Scholar
  36. Borris RP, Lankin DC, Cordell GA. Studies on the uleine alkaloids I. carbon-13 nmr studies on uleine, 20-epiuleine and (4S)-uleine-Nb-oxide. J Nat Prod. 1983;46:200–5.View ArticleGoogle Scholar
  37. Andrade-Neto VF, Pohlit AM, Pinto AC, Silva EC, Nogueira KL, Melo MR, et al. In vitro inhibition of Plasmodium falciparum by substances isolated from Amazonian antimalarial plants. Mem Inst Oswaldo Cruz. 2007;102:359–65.View ArticlePubMedGoogle Scholar
  38. Chierrito TP, Aguiar AC, de Andrade IM, Ceravolo IP, Goncalves RA, de Oliveira AJ, et al. Anti-malarial activity of indole alkaloids isolated from Aspidosperma olivaceum. Malar J. 2014;13:142.PubMed CentralView ArticlePubMedGoogle Scholar
  39. Yearick K, Ekoue-Kovi K, Iwaniuk DP, Natarajan JK, Alumasa J, de Dios AC, et al. Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines. J Med Chem. 2008;51:1995–8.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Dolabela et al. 2015

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement